Melisko Michelle E, Gradishar William J, Moy Beverly
From the UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Massachusetts General Hospital Cancer Center, Boston, MA.
Am Soc Clin Oncol Educ Book. 2016;35:e22-9. doi: 10.1200/EDBK_159203.
There are an estimated 3.1 million survivors of breast cancer in the United States. The predominant reasons for this substantially large population are that breast cancer is the most common noncutaneous malignancy among women and that 5-year survival rates after breast cancer treatment are approximately 90%. These patients have many medical considerations, including the need to monitor for disease recurrence and to manage complications of their previous cancer treatments. Most patients remain at risk indefinitely for local and systemic recurrences of their breast cancers and have an increased risk of developing contralateral new primary breast cancers. Therefore, optimizing care for this patient population is critical to the overall health care landscape in the United States. Here, we summarize survivorship care delivery and its challenges, the optimization of bone health in breast cancer survivors, and opportunities for risk reduction through lifestyle modifications.
据估计，美国有310万乳腺癌幸存者。这一庞大群体的主要原因是，乳腺癌是女性中最常见的非皮肤恶性肿瘤，且乳腺癌治疗后的5年生存率约为90%。这些患者有许多医疗方面的考量，包括监测疾病复发以及处理先前癌症治疗的并发症。大多数患者的乳腺癌局部和全身复发风险会无限期存在，且患对侧新发原发性乳腺癌的风险增加。因此，优化对这一患者群体的护理对于美国整体医疗格局至关重要。在此，我们总结了生存护理的提供及其挑战、乳腺癌幸存者骨骼健康的优化以及通过生活方式改变降低风险的机会。
